✦ LIBER ✦

From Bench to Bedside to Consumer: Where are the Regulatory Problems for Probiotics?

✍ Scribed by Reid, Gregor

Book ID: 121285198
Publisher: Walter de Gruyter GmbH & Co. KG
Year: 2005
Tongue: English
Weight: 268 KB
Volume: 2
Category: Article
ISSN: 2194-6329
DOI: 10.2202/1553-3840.1011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type 1 regulatory T (Tr1) cells: from th

Type 1 regulatory T (Tr1) cells: from the bench to the bedside

✍ Silvia Gregori, Rosa Bacchetta, Manuela Battaglia… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 79 KB

Tendinopathies — From bench to bed, wher

Tendinopathies — From bench to bed, where are the missing gaps?

✍ Chan Kai-Ming; Gang Li 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Basic research for the clinical trainee:

Basic research for the clinical trainee: from bedside to bench

✍ Rodney D. Newberry 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Neuroprotection for ischaemic stroke: Tr

Neuroprotection for ischaemic stroke: Translation from the bench to the bedside

✍ Brad A. Sutherland; Jens Minnerup; Joyce S. Balami; Francesco Arba; Alastair M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Genetic Therapy for Beta-Thalassemia: Fr

Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside

✍ Arumugam, P.; Malik, P. 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 172 KB

Cannabinoids as Pharmacotherapies for Ne

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside

✍ Elizabeth J. Rahn; Andrea G. Hohmann 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Neuropathic pain is a debilitating form of chronic pain resulting from nerve injury, disease states, or toxic insults. Neuropathic pain is often refractory to conventional pharmacotherapies, necessitating validation of novel analgesics. Cannabinoids, drugs that share the same target as Delta(9)-tetr